The European Patent Office (EPO) has granted patent EP3383999B1, titled "Stable dry compositions having no or little sugars." This patent, effective March 18, 2026, relates to specific formulations and their use, as indicated by the IPC classifications C12N (Microbiology; Enzymes; Mutants), A23K (Animal feed), A23L (Foodstuffs), and A61K (Preparations for medical and dental purposes). The designated states include a broad range of European countries.

This grant signifies a new intellectual property right in the field of biotechnology and pharmaceutical formulations. Companies operating in these sectors, particularly those developing or manufacturing products that require stable dry compositions, should review the patent claims to ensure they do not infringe upon this granted right. While this is a patent grant and not a regulatory rule imposing direct compliance obligations, it establishes exclusive rights that may affect product development, manufacturing, and market entry within the designated European states.